Drugmaker Indivior said on Monday it will pay $385 million to settle a lawsuit brought by direct purchasers on claims it illegally suppressed generic competition for its opioid addiction treatment Suboxone.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,